OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Angie Drakulich was editorial director of Pharmaceutical Technology.
January 02, 2013
FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, and overall approaches.
From time to time, it's important to take stock of the industry from both a retrospective and prospective point of view.
January 01, 2013
FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, overall approaches.
December 02, 2012
PDA's strategic plan calls for maintaining valuable and effective relationships with global regulators.
An interview with Eric M. Parker, Ph.D., Executive Director and Neuroscience Site Lead, Merck Research Laboratories, about the Merck BACE team's winning research.
A look at the year's leaders in innovation strategy, including the top bio/pharmaceutical companies and award recipients from AAPS, PhRMA, and CPhI.